These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 23852663

  • 1. Liver transplantation for hepatitis B liver disease and concomitant hepatocellular carcinoma in the United States With hepatitis B immunoglobulin and nucleoside/nucleotide analogues.
    Campsen J, Zimmerman M, Trotter J, Hong J, Freise C, Brown R, Cameron A, Ghobrial M, Kam I, Busuttil R, Saab S, Holt C, Emond J, Stiles J, Lukose T, Chang M, Klintmalm G.
    Liver Transpl; 2013 Sep; 19(9):1020-9. PubMed ID: 23852663
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. High-dose hepatitis B immunoglobulin therapy in hepatocellular carcinoma with hepatitis B virus-DNA/hepatitis B e antigen-positive patients after living donor liver transplantation.
    Lee EC, Kim SH, Lee SD, Park H, Lee SA, Park SJ.
    World J Gastroenterol; 2016 Apr 14; 22(14):3803-12. PubMed ID: 27076765
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Extended survival of patients with persistently suppressed hepatitis B transplanted for hepatocellular carcinoma.
    Viganò M, Bhoori S, Lampertico P, Donato MF, Iavarone M, Grossi G, Facciorusso A, Caccamo L, Rossi G, Colombo M, Mazzaferro V.
    Liver Int; 2015 Sep 14; 35(9):2187-93. PubMed ID: 25809541
    [Abstract] [Full Text] [Related]

  • 7. Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation.
    Faria LC, Gigou M, Roque-Afonso AM, Sebagh M, Roche B, Fallot G, Ferrari TC, Guettier C, Dussaix E, Castaing D, Brechot C, Samuel D.
    Gastroenterology; 2008 Jun 14; 134(7):1890-9; quiz 2155. PubMed ID: 18424269
    [Abstract] [Full Text] [Related]

  • 8. Antiviral treatment for hepatitis B virus recurrence following liver transplantation.
    Lee S, Kwon CH, Moon HH, Kim TS, Roh Y, Song S, Shin M, Kim JM, Park JB, Kim SJ, Joh JW, Lee SK.
    Clin Transplant; 2013 Jun 14; 27(5):E597-604. PubMed ID: 24093615
    [Abstract] [Full Text] [Related]

  • 9. The relationship between HBcrAg and HBV reinfection in HBV related post-liver transplantation patients.
    Urabe A, Imamura M, Tsuge M, Kan H, Fujino H, Fukuhara T, Masaki K, Kobayashi T, Ono A, Nakahara T, Kawaoka T, Hiramatsu A, Kawakami Y, Aikata H, Hayes CN, Maki N, Ohdan H, Chayama K.
    J Gastroenterol; 2017 Mar 14; 52(3):366-375. PubMed ID: 27422771
    [Abstract] [Full Text] [Related]

  • 10. Diabetes mellitus may affect the long-term survival of hepatitis B virus-related hepatocellular carcinoma patients after liver transplantation.
    Zhang Q, Deng YL, Liu C, Huang LH, Shang L, Chen XG, Wang LT, Du JZ, Wang Y, Wang PX, Zhang H, Shen ZY.
    World J Gastroenterol; 2016 Nov 21; 22(43):9571-9585. PubMed ID: 27920478
    [Abstract] [Full Text] [Related]

  • 11. Liver transplantation in patients with hepatitis B virus-related hepatocellular carcinoma: the influence of viral characteristics on clinical outcome.
    Wu TJ, Chan KM, Chou HS, Lee CF, Wu TH, Chen TC, Yeh CT, Lee WC.
    Ann Surg Oncol; 2013 Oct 21; 20(11):3582-90. PubMed ID: 23760589
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prognosis in liver transplantation recipients after hepatitis B virus recurrence.
    Sun LY, Zhu ZJ, Qu W, Sun XY, Rao W, Liu Y.
    Hepatogastroenterology; 2014 Oct 21; 61(135):2047-51. PubMed ID: 25713909
    [Abstract] [Full Text] [Related]

  • 15. Hepatitis B prophylaxis using lamivudine and individualized low-dose hepatitis B immunoglobulin in living donor liver transplantation.
    Jiang L, Yan L, Wen T, Li B, Zhao J, Yang J, Xu M, Wang W.
    Transplant Proc; 2013 Oct 21; 45(6):2326-30. PubMed ID: 23953544
    [Abstract] [Full Text] [Related]

  • 16. [The relationship between hepatocellular carcinoma recurrence and hepatitis B virus recurrence after liver transplantation].
    Li MR, Yi SH, Cai CJ, Yi HM, An YL, Wei M, Chen GH.
    Zhonghua Gan Zang Bing Za Zhi; 2011 Apr 21; 19(4):271-4. PubMed ID: 21586225
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Recurrent hepatitis B following recurrence of hepatocellular carcinoma after living donor liver transplantation.
    Ijichi H, Yoshizumi T, Ikegami T, Soejima Y, Ikeda T, Kawanaka H, Uchiyama H, Yamashita Y, Morita M, Oki E, Mimori K, Sugimachi K, Saeki H, Watanabe M, Shirabe K, Maehara Y.
    Fukuoka Igaku Zasshi; 2013 Oct 21; 104(10):376-82. PubMed ID: 24511669
    [Abstract] [Full Text] [Related]

  • 19. Comparison of clinical outcomes in chronic hepatitis B liver transplant candidates with and without hepatocellular carcinoma.
    Wong SN, Reddy KR, Keeffe EB, Han SH, Gaglio PJ, Perrillo RP, Tran TT, Pruett TL, Lok AS.
    Liver Transpl; 2007 Mar 21; 13(3):334-42. PubMed ID: 17154401
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.